Granzyme A Participates in the Pathogenesis of Infection-Associated Acute Encephalopathy.

acute encephalopathy acute encephalopathy with biphasic seizures and late reduced diffusion complex febrile seizures cytokine granzyme A

Journal

Journal of child neurology
ISSN: 1708-8283
Titre abrégé: J Child Neurol
Pays: United States
ID NLM: 8606714

Informations de publication

Date de publication:
03 2020
Historique:
pubmed: 12 11 2019
medline: 21 7 2021
entrez: 12 11 2019
Statut: ppublish

Résumé

The present study aimed to determine whether granzymes are implicated in the pathogenesis of infection-associated acute encephalopathy (AE). We investigated granzyme and cytokine levels in the cerebrospinal fluid of patients with acute encephalopathy or complex febrile seizures (cFS). A total of 24 acute encephalopathy patients and 22 complex febrile seizures patients were included in the present study. Levels of granzymes A and B were measured using enzyme-linked immunosorbent assay, and levels of tumor necrosis factor α (TNF-α), interferon-γ (IFN-γ), interleukin 1β (IL-1β), IL-1 receptor antagonist (IL-1RA), IL-4, IL-6, IL-8, and IL-10 were assessed using the Bio-Plex suspension array system. Cerebrospinal fluid levels of granzyme A were significantly higher, and those of TNF-α and IL-1RA were significantly lower in the AE group than in the cFS group; however, no significant differences in the levels of granzyme B, IFN-γ, IL-1β, IL-4, IL-6, IL-8, and IL-10 were observed between the 2 groups. In addition, no significant differences in granzyme A, granzyme B, or cytokine levels were observed between acute encephalopathy patients with and those without neurologic sequelae. Our findings indicate the involvement of granzyme A in the pathogenesis of acute encephalopathy.

Identifiants

pubmed: 31709864
doi: 10.1177/0883073819886217
doi:

Substances chimiques

Granzymes EC 3.4.21.-
GZMA protein, human EC 3.4.21.78

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

208-214

Auteurs

Gaku Yamanaka (G)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Shinichiro Morichi (S)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Tomoko Takamatsu (T)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Ryou Takahashi (R)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Yusuke Watanabe (Y)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Yu Ishida (Y)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Mika Takeshita (M)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Natsumi Morishita (N)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Akiko Kasuga (A)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Kanako Kanou (K)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Singo Oana (S)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Shunsuke Suzuki (S)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Soken Go (S)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Yasuyo Kashiwagi (Y)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Hisashi Kawashima (H)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH